- Drug Pipelines
- April 2025
- 60 Pages
Global
From €879EUR$1,000USD£766GBP
€1099EUR$1,250USD£958GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €879EUR$1,000USD£766GBP
€1099EUR$1,250USD£958GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €879EUR$1,000USD£766GBP
€1099EUR$1,250USD£958GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €879EUR$1,000USD£766GBP
€1099EUR$1,250USD£958GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €879EUR$1,000USD£766GBP
€1099EUR$1,250USD£958GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €879EUR$1,000USD£766GBP
€1099EUR$1,250USD£958GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €879EUR$1,000USD£766GBP
€1099EUR$1,250USD£958GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €879EUR$1,000USD£766GBP
€1099EUR$1,250USD£958GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €879EUR$1,000USD£766GBP
€1099EUR$1,250USD£958GBP
- Report
- May 2025
- 110 Pages
Global
From €4176EUR$4,750USD£3,639GBP
- Report
- December 2025
- 377 Pages
Global
From €5143EUR$5,850USD£4,482GBP
- Report
- December 2025
- 361 Pages
Global
From €5143EUR$5,850USD£4,482GBP
- Report
- December 2025
- 390 Pages
Global
From €5143EUR$5,850USD£4,482GBP
- Report
- December 2025
- 370 Pages
Global
From €5143EUR$5,850USD£4,482GBP
- Report
- December 2025
- 570 Pages
Global
From €5143EUR$5,850USD£4,482GBP
- Report
- December 2025
- 294 Pages
Global
From €5143EUR$5,850USD£4,482GBP
- Report
- December 2025
- 212 Pages
Global
From €5143EUR$5,850USD£4,482GBP
- Report
- December 2025
- 387 Pages
Global
From €5143EUR$5,850USD£4,482GBP
- Report
- December 2025
- 383 Pages
Global
From €5143EUR$5,850USD£4,482GBP
- Report
- December 2025
- 383 Pages
Global
From €5143EUR$5,850USD£4,482GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more